Cantel Medical Corporation (CMD)
| Market Cap | 3.40B |
| Revenue (ttm) | 1.06B |
| Net Income (ttm) | 32.41M |
| Shares Out | 42.16M |
| EPS (ttm) | 0.76 |
| PE Ratio | 105.82 |
| Forward PE | 31.25 |
| Dividend | $0.21 |
| Dividend Yield | 0.26% |
| Trading Day | January 21 |
| Last Price | $80.00 |
| Previous Close | $80.35 |
| Change ($) | -0.35 |
| Change (%) | -0.44% |
| Day's Open | 80.13 |
| Day's Range | 79.46 - 80.47 |
| Day's Volume | 581,418 |
| 52-Week Range | 21.76 - 84.66 |
WILMINGTON, Del., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Cantel Medical Corp. (“Cantel”) (NYSE: CMD) regarding possible breaches of fiduciary ...
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cantel M...
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in Ne...
Does Cantel Medical (CMD) have what it takes to be a top stock pick for momentum investors? Let's find out.
STERIS (STE) expects to strengthen and expand its endoscopy offerings along with extending into a new customer territory via the Cantel Medical buyout.
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cantel Medical Corp. (NYSE: CMD) concerning ...
NEW YORK, Jan. 12, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cantel Medical Corp. ("CMD" o...
NEW YORK, Jan. 12, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Cantel Medical Corporation (NYSE: CMD) ("Cantel") and its board of directors con...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether Cantel Medical Corp. (NYSE: CMD) and its board of directors violated the federal securi...
Shares of Cantel Medical Corp. rose 1.8% in premarket trading Tuesday, after the infection prevention products company announced an agreement to be acquired by Ireland-based Steris PLC in a ca...
Top Ranked Momentum Stocks to Buy for December 23rd
Cantel (CMD) possesses solid growth attributes, which could help it handily outperform the market.
Top Ranked Momentum Stocks to Buy for December 21st
Cantel (CMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Cantel Medical Corp. (CMD) CEO George Fotiades on Q1 2021 Results - Earnings Call Transcript
iBio (NYSE: IBIO) shares are trading lower on Tuesday after the company announced a common stock offering. iBio's main area of business is plant-based protein expression technologies for vacci...
The company's latest quarterly earnings report managed to impress investors.
Cantel (CMD) delivered earnings and revenue surprises of 150.00% and 1.55%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Cantel Medical (NYSE:CMD) were unchanged in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 38.46% over the past year to $0.90, wh...
LITTLE FALLS, N.J., Dec. 8, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its first quarter ended October 31, 2020. First quarter 2021 net sales w...
LITTLE FALLS, N.J., Dec. 7, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) and Censis Technologies announced today a new long-term partnership to combine Cantel's leading infection preve...
FRANKLIN, Tenn.--(BUSINESS WIRE)--Today, Censis Technologies, a wholly owned subsidiary of Fortive Corporation, and Cantel Medical Corp announced a new long-term partnership to combine Cantel'...
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cantel Medical has the legs to reach historical growth levels over the coming periods, backed by a strong Q4 performance. Q1 pre-announcements have indicated a stronger than expected sales rec...
Cantel (CMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
COVID-19 has heightened the demand for companies that specialize in infection control.
The Covid-19 pandemic has given a significant boost to many industries such as manufacturers of gloves, masks, sanitizers, PPE (personal protective equipment), health insurance providers, and ...
CHICAGO, Oct. 1, 2020 /PRNewswire/ -- HuFriedyGroup, the dental division of Cantel Medical Corp. (NYSE: CMD), and a global leader in infection prevention, dental instrument manufacturing, and ...
Cantel Medical Corp. (CMD) CEO George Fotiades on Q4 2020 Results - Earnings Call Transcript
Cantel (CMD) delivered earnings and revenue surprises of 200.00% and 0.14%, respectively, for the quarter ended July 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Cantel Medical (NYSE:CMD) moved higher by 4.9% in pre-market trading after the company reported Q4 results.
LITTLE FALLS, N.J., Sept. 17, 2020 /PRNewswire/ -- Cantel Medical Corp.
Cantel Medical (NYSE: CMD) announces its next round of earnings this Thursday, September 17.
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LITTLE FALLS, N.J., Sept. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP.
LITTLE FALLS, N.J., Aug. 6, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP.
LITTLE FALLS, N.J., Aug. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP.
Cantel Medical Corp. (CMD) CEO George Fotiades on Q3 2020 Results - Earnings Call Transcript
Cantel (CMD) delivered earnings and revenue surprises of 14.29% and 0.54%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Cantel Medical (NYSE:CMD) were flat in pre-market trading after the company reported Q3 results.
LITTLE FALLS, N.J., June 4, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its third quarter ended April 30, 2020. Third quarter 2020 net sales wer...
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LITTLE FALLS, N.J., May 22, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) ("Cantel" or the "Company") today announced the sale of $28 million in aggregate principal amount of its 3.25% ...
The medical device company missed Wall Street estimates in Q2 and lowered its full-year outlook in part due to the negative impact of the COVID-19 coronavirus.
Cantel Medical Corp. (CMD) CEO George Fotiades on Q2 2020 Results - Earnings Call Transcript
Cantel (CMD) delivered earnings and revenue surprises of -10.29% and -1.60%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cantel Medical has taken the necessary steps to improve the business, and I expect to see earning growth similar to what it was in the past.
Expect insider filing volumes to increase again in the first week of February and stay strong through the end of March.
About CMD
Cantel Medical provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life ... [Read more...]
| Industry Medical Instruments & Supplies | Founded 1963 |
| CEO George Fotiades | Employees 3,669 |
| Stock Exchange NYSE | Ticker Symbol CMD |
Financial Performance
In 2020, Cantel Medical's revenue was $1.02 billion, an increase of 10.66% compared to the previous year's $918.16 million. Earnings were $13.71 million, a decrease of -75.10%.
Analyst Forecasts
According to 7 analysts, the average rating for Cantel Medical stock is "Hold." The 12-month stock price forecast is 73.50, which is a decrease of -8.13% from the latest price.